SAN DIEGO, Sept. 14, 2023 /PRNewswire/ — Phanes Therapeutics, Inc. (Phanes), a clinical stage biotech company focused on innovative drug discovery and development in oncology, today announced that Professor Shun Lu, an internationally renowned oncologist and professor at Shanghai Jiao…
Month: September 2023
BANGALORE, Índia, 14 de setembro de 2023 /PRNewswire/ — A 42Gears, líder em gestão de mobilidade empresarial, tem o prazer de anunciar o lançamento do AstroStatus, uma solução intuitiva de comunicação de incidentes desenvolvida para capacitar as empresas, mantendo seus clientes…
ATLANTA, Sept. 14, 2023 /PRNewswire/ — PROPEL Center today announced that the U.S. Department of Education has named its President, Dr. Lisa N. Herring, as Strategic Advisor to the Secretary. Herring, who officially begins her tenure with PROPEL on Monday, September 18th, will help shape…
V utorok sa v Paríži zišli najvyšší politickí predstavitelia a poprední predstavitelia podnikateľského sektora z Afriky a Kórejskej republiky, aby diskutovali o regionálnej integrácii, priemyselnej produktivite a spôsoboch ďalšieho hospodárskeho rastu a spolupráce. Na obchodnom samite…
Crop for 2023 is on par with four-year average MILWAUKIE, Ore., Sept. 14, 2023 /PRNewswire/ — As autumn arrives, Pacific Northwest orchards are bursting with fresh pears and kicking off the fall harvest season to fill produce shelves across America with a versatile, flavorful and…
Strengthen cellular analysis with cost-efficient multiomic readouts and streamlined workflows PLEASANTON, Calif., Sept. 14, 2023 /PRNewswire/ — 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today the commercial availability of a new kit to…
CHICAGO, Sept. 14, 2023 /PRNewswire/ — Conagra Brands, Inc. (NYSE: CAG) today announced that Francisco Fraga, 50, has been elected to its board of directors at its annual meeting of shareholders held earlier today. All director nominees were elected to the board of directors, which…
Scientists used a new method to screen 10,000 combinations of gene edits in immune cells engineered to fight cancer SAN FRANCISCO, Sept. 14, 2023 /PRNewswire/ — In recent years, scientists have used gene modification technologies to reprogram immune cells into therapeutics that can…
CHARLOTTE, N.C., Sept. 14, 2023 /PRNewswire/ — Nucor Corporation (NYSE: NUE) today announced guidance for its third quarter ending September 30, 2023. Nucor expects third quarter earnings to be in the range of $4.10 to $4.20 per diluted share. Nucor reported net earnings of $5.81 per…
HOUSTON, Sept. 14, 2023 /PRNewswire/ — KBR (NYSE: KBR) announced today that its commercial cloud and mission service platform, KBR Vaault®, has been prioritized for the Federal Risk and Authorization Management Program (FedRAMP®) Joint Authorization Board (JAB) authorization process….